Effects of ILTG on DAPK1 promoter methylation in colon and leukemia cancer cell lines

Anticancer Research

Volumn 30, Issue 10, 2010, Pages 3945-3950

  Zorko, Bryan A ^a   Bueno Pérez, Lynette ^a   Carcache De Blanco, Esperanza J ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

DAPK 1; DNA methylation; HL 60; HT 29; ILTG; MSP MCA

Indexed keywords

ANTINEOPLASTIC AGENT; ELLIPTICINE; ETHIDIUM BROMIDE; ISOLIQURITIGENIN; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER PREVENTION; COLON CANCER; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; DRUG CYTOTOXICITY; DRUG SCREENING; GLYCYRRHIZA GLABRA; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMIA CELL LINE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

APOPTOSIS REGULATORY PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CHALCONES; COLONIC NEOPLASMS; DNA METHYLATION; ENZYME INHIBITORS; HL-60 CELLS; HT29 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; PROMOTER REGIONS, GENETIC;

EID: 78650252905     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. FASTSTATS - Leading Causes of Death. [http://www.cdc.gov/nchs/fastats/ lcod.htm]
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T and Thun MJ: Cancer Statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
3. The National Cancer Institute: What You Need To Know About ™Leukemia. [http://www.cancer.gov/cancertopics/wyntk/leukemia/page1].
4. Yi A-K and Krieg AM: CPG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of IκBα and IκBβ and sustained activation of nuclear factor-κB/c-Rel. J Immunol 160: 1240-1245, 1998.
5. Kwon H-J, Lee K-W, Yu SH, Han JH and Kim D-S: NF-κB-dependent regulation of tumor necrosis factor-α gene expression by CpG-oligodinucleotides. Biochem Biophys Res Comm 311(1): 129-138, 2003.
6. Shen W, Waldschmidt M, Zhao X, Ratliff T and Krieg AM: Antitumor mechanisms of oligodeoxynucleotides with CpG and PolyG motifs in murine prostate cancer cells: decrease of NF-κB and AP-1 binding activities and induction of apoptosis. Antisense Nucl Acid Drug Dev 12(3): 155-164, 2002.
7. Ichikawa H, Takada Y, Shishodia S, Jayaprakasam B, Nair MG and Aggarwal BB: Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogensis through suppression of nuclear factor-κB (NF-κB) activation and NF-κB-regulated gene expression. Mol Canc Ther 5: 1434-1445, 2006.
8. Patra SK, Patra A and Dahiya R: Histone deacetylase and DNA methyltransferase in human prostate cancer. Biochem Biophys Res Commun 287: 705-713, 2001.
9. Satoh A, Toyota M, Itoh F, Kikuchi T, Obata T, Sasaki Y, Suzuki H, Yawata A, Kusano M, Fujita M, Hosokawa M, Yanagihara K, Tokino T and Imai K: DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers. Br J Cancer 86: 1817-1823, 2002.
10. Tozawa T, Tamura G, Honda T, Nawata S, Kimura W, Makino N, Kawata S, Sugai T, Suto T and Motoyama T: Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients. Canc Sci 95: 736-740, 2004.
11. Galm O, Wilop S, Reichelt J, Jost E, Gehbauer G, Herman JG and Osieka R: DNA methylation changes in multiple myeloma. Leukemia 18: 1687-1692, 2004.
12. Yamaguchi S, Asao T, Nakamura J, Ide M and Kuwano H: High frequency of DAP-kinase gene promoter methylation in colorectal cancer specimens and its identification in serum. Cancer Lett 194: 99-105, 2003.
13. Chan EC, Lam SY, Tsang KW, Lam B, Ho JCM, Fu KH, Lam WK and Kwong YL: Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: Patterns in primary tumors and potential diagnostic application in bronchalveolar lavage. Clin Canc Res 8: 3741-3746, 2002.
14. Raval A, Tanner SM, Byrd JC, Angerman EB, Perko JD, Chen SS, Hackanson B, Grever MR, Lucas DM, Matkovic JJ, Lin TS, Kipps TJ, Murray F, Weisenburger D, Sanger W, Lynch J, Watson P, Jansen M, Yoshinaga Y, Rosenquist R, de Jong PJ, Coggill P, Beck S, Lynch H, de la Chapelle A and Plass C: Downregulation of death associated protein kKinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 129: 879-890, 2007.
15. Balunas MJ, Su B, Brueggemeier RW and Kinghorn AD: Xanthones from the botanical dietary supplement mangosteen (Garcinia mangostana) with aromatase inhibitory activity. J Nat Prod 71: 1161-1166, 2008.
16. Jang D, Park EJ, Kang Y-H, Hawthorne ME, Vigo JS, Graham JG, Cabieses F, Fong HHS, Mehta RG, Pezzuto JM and Kinghorn AD: Potential cancer chemopreventive flavonoids from the stems of Tephrosia toxicaria. J Nat Prod 66: 1166-1170, 2003.
17. Nakatani K, Yamakuni T, Kondo N, Arakawa T, Oosawa K, Shimura S, Inoue H and Ohizumi Y: γ-Mangostin inhibits inhibitor-kappa B kinase activity and decreases lipopolysaccharide-induced cyclooxygenase-2 gene expression in C6 rat glioma cells. Mol Pharmacol 66: 667-674, 2004.
18. Kim J-Y, Park SJ, Yun K-J, Cho Y-W, Park H-J and Lee K-T: Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages. Eur J Pharmacol 584: 175-184, 2008.
19. Herman JG, Graff JR, Myöhänen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation Status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996.
20. Lorente A, Mueller W, Urdangarín E, Lázcoz P, von Deimling A and Castresana JS: Detection of methylation in promoter sequences by melting curve analysis-based semiquantitative real time PCR. BMC Cancer 8: 61, 2008.
21. Guldberg P, Worm J and Grønbæk K: Profiling DNA methylation by melting analysis. Methods 27: 121-127, 2002.
22. Kim J-A, Lau EK, Pan L and Carcache de Blanco EJ: NF-κB Inhibitors from Brucea javanica exhibiting intracellular effects on reactive oxygen species. Anticancer Res 30(9): 2010 (In press).
23. Kitawaza S and Kitazawa R: Epigenetic control of mouse receptor activator of NF-κB ligand gene expression. Biochem Biophys Res Commun 293: 126-131, 2002.
24. Amalfitano A and Chamberlain JS: The mdx-amplification-resistant mutation system assay, a simple and rapid polymerase chain reaction-based detection of the mdx allele. Muscle Nerve 19: 1549-1553, 1996.
25. Clendening B: UV Spectrophotometry [http://people.hofstra.edu/Beverly- Clendening/Adv-Molecular-Biology/Protocols/UV-Spec-Analysis-RNA&DNA.htm].
26. Lawrence R and Pikaard CS: Bisulfite Genomic DNA Sequencing. [http://biology4.wustl.edu/pikaard/PDFs%20 and %20protocol%20files%20/ Bisulfite%20Sequencing.pd].
27. He X-J, Hsu Y-F, Zhu S, Wierzbicki AT, Pontes O, Pikaard CS, Liu H-L, Wang C-S, Jin H and Zhu J-K: An effector of RNA-directed DNA methylation in arabidopsis is an ARGONAUTE 4- and RNA-binding protein. Cell 137: 498-508, 2009.
28. He X-J, Hsu Y-F, Zhu S, Pontes O, Zhu J, Lu J, Bressan RA, Pikaard CS, Wang C-S and Zhu J-K: NRPD4, a protein related to the RBP4 subunit of RNA polymerase II, is a component of RNA polymerases IV and V and is required for RNA-directed DNA methylation. Genes Dev 23: 318-330, 2009.
29. Katzenellenbogen RA, Baylin SB and Herman JG: Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood 93: 4347-4353, 1999.
30. Burre NS, Frigo A, Rasmussen RR and McAlpine JB: A colorimetric microassay for the detection of agents that interact with DNA. J Nat Prod 55: 1582-1587, 1992.
31. Sánchez-Medina A, García-Sosa K, May-Pat F and Peña-Rodríguez LM: Evaluation of the biological activity of crude extracts from plants used in Yucatecan traditional medicine. Part II. DNA-interacting activity. Phytomedicine 8: 236-239, 2001.